Pharma Mar, S.A. (VIE:PHM)
Austria
· Delayed Price · Currency is EUR 80.15
+1.25 (1.58%)
At close: Mar 9, 2026
Pharma Mar Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,384 | 1,389 | 738 | 1,158 | 1,033 | 1,313 | Upgrade
|
| Market Cap Growth | -17.92% | 88.09% | -36.23% | 12.13% | -21.36% | 66.27% | Upgrade
|
| Enterprise Value | 1,287 | 1,298 | 608 | 1,014 | 866 | 1,176 | Upgrade
|
| Last Close Price | 78.90 | 75.65 | 40.59 | 63.01 | - | - | Upgrade
|
| PE Ratio | 40.69 | 53.17 | 649.51 | 23.46 | 11.12 | 9.57 | Upgrade
|
| PS Ratio | 7.72 | 7.94 | 4.67 | 5.90 | 4.49 | 4.87 | Upgrade
|
| PB Ratio | 7.01 | 6.67 | 3.82 | 5.19 | 5.81 | 12.78 | Upgrade
|
| P/TBV Ratio | 7.05 | 6.70 | 3.84 | 5.22 | 5.84 | 12.91 | Upgrade
|
| P/FCF Ratio | 82.76 | - | - | 39.30 | 57.78 | 4.76 | Upgrade
|
| P/OCF Ratio | 65.15 | 230.47 | - | 30.22 | 40.22 | 4.71 | Upgrade
|
| EV/Sales Ratio | 7.18 | 7.42 | 3.84 | 5.17 | 3.77 | 4.36 | Upgrade
|
| EV/EBITDA Ratio | 44.28 | 128.91 | - | 22.60 | 9.12 | 7.39 | Upgrade
|
| EV/EBIT Ratio | 58.52 | 200.70 | - | 24.11 | 9.37 | 7.51 | Upgrade
|
| EV/FCF Ratio | 76.99 | - | - | 34.42 | 48.46 | 4.26 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.25 | 0.23 | 0.19 | 0.28 | 0.55 | Upgrade
|
| Debt / EBITDA Ratio | 1.73 | 4.19 | 48.68 | 0.91 | 0.51 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 3.01 | - | - | 1.45 | 2.76 | 0.21 | Upgrade
|
| Net Debt / Equity Ratio | -0.49 | -0.50 | -0.61 | -0.63 | -0.86 | -1.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.57 | -10.27 | 103.75 | -3.11 | -1.61 | -0.87 | Upgrade
|
| Net Debt / FCF Ratio | -5.76 | 11.51 | 4.21 | -4.74 | -8.53 | -0.50 | Upgrade
|
| Asset Turnover | 0.53 | 0.51 | 0.43 | 0.52 | 0.66 | 1.19 | Upgrade
|
| Inventory Turnover | 0.20 | 0.18 | 0.29 | 0.71 | 1.46 | 1.32 | Upgrade
|
| Quick Ratio | 2.03 | 2.29 | 1.98 | 2.18 | 2.93 | 2.31 | Upgrade
|
| Current Ratio | 2.73 | 3.03 | 2.63 | 2.83 | 3.42 | 2.59 | Upgrade
|
| Return on Equity (ROE) | 17.91% | 13.00% | 0.55% | 24.62% | 66.18% | 249.16% | Upgrade
|
| Return on Assets (ROA) | 4.08% | 1.17% | -0.65% | 6.91% | 16.54% | 43.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.47% | 7.21% | -4.85% | 77.52% | - | 808.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.70% | 2.40% | -1.60% | 14.20% | 32.80% | 66.60% | Upgrade
|
| Earnings Yield | 2.46% | 1.88% | 0.15% | 4.26% | 8.99% | 10.45% | Upgrade
|
| FCF Yield | 1.21% | -0.65% | -3.83% | 2.54% | 1.73% | 21.01% | Upgrade
|
| Dividend Yield | 1.01% | 1.06% | 1.60% | 1.03% | - | - | Upgrade
|
| Payout Ratio | 41.02% | 43.71% | 1028.06% | 23.83% | 11.71% | 6.42% | Upgrade
|
| Buyback Yield / Dilution | - | 1.98% | 0.81% | 0.12% | 1.31% | 0.77% | Upgrade
|
| Total Shareholder Return | 1.01% | 3.03% | 2.42% | 1.15% | 1.31% | 0.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.